On central effects of serotonin re-uptake inhibitors: Quantitative EEG and psychometric studies with sertraline and zimelidine
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
In a double-blind placebo-controlled cross-over study the encephalotropic and psychotropic properties of sertraline--a new potent and highly selective inhibitor of synaptosomal serotonin uptake--were studied along with blood levels of the parent drug and main metabolite in ten normal healthy volunteers. They received randomized at weekly intervals oral single doses of placebo, 100, 200 and 400 mg setraline and 100 mg zimelidine as reference drug. Blood sampling, EEG recordings, psychometric tests and evaluation of pulse, blood pressure and side-effects were carried out at the hours 0, 2, 4, 6, and 8. Blood level investigations demonstrated that sertraline is slowly absorbed with dose-dependent blood concentrations peaking in the 4th to 6th hour and remaining high thereafter, while the main metabolite, CP-53261 exhibited an even slower rise in plasma concentration up to the 8th hour. Computer-assisted spectral analysis of the EEG demonstrated slight effects of 100 mg zimelidine and 100 mg sertraline on human brain function, but moderate to marked effects after 200 and 400 mg sertraline as compared with placebo. Changes after 100 mg sertraline and the reference compound resembled the pharmaco-EEG profiles of antidepressants of the desipramine type and were indicative of some vigilance-improving properties while higher doses of sertraline induced alterations reminiscent of those after antidepressants of the imipramine type, thereby reflecting vigilance changes of the dissociativ…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“single oral doses of 400 mg sertraline administered to healthy volunteers gave maximum plasma concentrations of 253.20 ± 112.29 ng/ml (~0.74μM) (Saletu et al., 1986)”
From Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent (2012) · cites this paper as Saletu et al., 1986
Citations
Cites
Osgood, C. E., Suci, G. J., & Tannenbaum, P. H. (1957) · Cited by 9,433
5-HIAA in the Cerebrospinal Fluid: A Biochemical Suicide Predictor?
Åsberg, M. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770100055005 · Cited by 1,445
Psychopharmacology: A Generation of Progress
Ananth, J. (1979) · Psychosomatics · doi:10.1016/s0033-3182(79)73729-7 · Cited by 844
5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides
Shaw, D. M., Camps, F. E., & Eccleston, E. G. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.505.1407 · Cited by 431
Ashcroft, G. W., Crawford, T. B. B., Eccleston, D., Sharman, D. F., Macdougall, E., Stanton, J. B., & Binns, J. K. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92028-9 · Cited by 373
BOURNE, H. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92459-8 · Cited by 304
Abnormalities of Indoleamines in Affective Disorders
Coppen, A. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750230084016 · Cited by 304 · cited 1×
“, 1968) and from cerebral spinal fluid (CSF) data of patients with affective disorders (Ashcroft et al., 1966; Dencker et al., 1966; Shaw et al., 1969; Coppen et al., 1972).”
BackgroundOreland, L., Wiberg, Å., Åsberg, M., Träskman, L., Sjöstrand, L., Thorén, P., Bertilsson, L., & Tybring, G. (1981) · Psychiatry Research · doi:10.1016/0165-1781(81)90004-4 · Cited by 273 · cited 1×
“Oreland et al. (1981) described a bimodal distribution of CSF 5-HIAA in depressed patients, with the ones having lower values also showing greater suicidal behaviour.”
BackgroundKoe, B. K., Weissman, A., Welch, W. M., & Browne, R. G. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21773-6 · Cited by 257
ACID MONOAMINE METABOLITES OF CEREBROSPINAL FLUID IN MENTAL DEPRESSION AND MANIA
Dencker, S. J., Malm, U., Roos, B. ‐., & Werdinius, B. (1966) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1966.tb04320.x · Cited by 218 · cited 1×
“, 1968) and from cerebral spinal fluid (CSF) data of patients with affective disorders (Ashcroft et al., 1966; Dencker et al., 1966; Shaw et al., 1969; Coppen et al., 1972).”
Background
Research works printed but not linked: 8
- Grünberger J (1977) Psychodiagnostik des Alkoholkranken. Methodischer Beitrag zur Bestimmung der Organizität in der Psychiatrie. Maudrich, Wien
- Grünberger J, Linzmayer L, Saletu B (1984) Klinische Psychodiagnostik mit Hilfe psychophysiologischer Verfahren. Wien Med Wschr 134: 29?35
- Pfizer (1982) Central research: sertraline (CP-51, 974) ? investigators reference manual. Sandwich, England
- Saito M, Kita S, Kagono Y (1982) The orientation of psychotropic drug properties based on the induced changes in electroencephalogram. Studies on zimelidine and sulpiride. In: Herrmann WM (ed) EEG in drug research. G. Fischer, Stuttgart New York, pp 51?74
- Saletu B (1976) Psychopharmaka, Gehirntätigkeit und Schlaf. Karger, Basel
- Saletu B (1981) Application of quantitative EEG in measuring encephalotropic and pharmacodynamic properties of antihypoxidotic/nootropic drugs. In: Scientific International Research (ed) Drugs and methods in C.V.D. Pergamon Press, Oxford
- Spiegel R, Aebi H-J (1981) Psychopharmakologie. W Kohlhammer, Stuttgart Berlin Köln Mainz
- Zerssen VC, Koeller DM, Rey ER (1970) Die Befindlichkeitsskala (B-S) ? ein einfaches Instrument zur Objektivierung von Befindlichkeitsstörungen, insbesondere im Rahmen von Längsschnittuntersuchungen. Arzneim-Forsch 20: 915?918
Cited by
Clinical Pharmacokinetics of Sertraline
DeVane, C. L., Liston, H. L., & Markowitz, J. S. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241150-00002 · Cited by 404
Serotonin and Blood Pressure Regulation
Watts, S. W., Morrison, S. F., Davis, R. P., & Barman, S. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004697 · Cited by 396
Wake and sleep EEG provide biomarkers in depression
Steiger, A., & Kimura, M. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.08.013 · Cited by 302
Murdoch, D., & McTavish, D. (1992) · Drugs · doi:10.2165/00003495-199244040-00007 · Cited by 232
Lines of Evidence on the Risks of Suicide with Selective Serotonin Reuptake Inhibitors
Healy, D. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000068691 · Cited by 220
“Among the published studies with sertraline, 1 demonstrates a clear dose-dependent induction of agitation with sertraline [ 62 ].”
BackgroundEarly Changes in Prefrontal Activity Characterize Clinical Responders to Antidepressants
Cook, I. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00294-4 · Cited by 193
Goldstein, B. J., & Goodnick, P. J. (1998) · Journal of Psychopharmacology · doi:10.1177/0269881198012003041 · Cited by 171
Kemp, A. H., Gordon, E., Rush, A. J., & Williams, L. M. (2008) · CNS Spectrums · doi:10.1017/s1092852900017120 · Cited by 170
Metabolism and Pharmacokinetics of Selective Serotonin Reuptake Inhibitors
DeVane, C. L. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006934807375 · Cited by 149
“Saletu et al. (1986) described a slow appearance of parent drug in plasma, with peak concentrations 4–6 hr after ingestion.”
BackgroundPrevalence and outcome of partial remission in depression
Tranter, R., O’Donovan, C., Chandarana, P., & Kennedy, S. (2002) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0242 · Cited by 145
Relationship of anger and anger attacks with depression
Painuly, N., Sharan, P., & Mattoo, S. K. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0539-5 · Cited by 124
EEG Topography and Tomography (LORETA) in Diagnosis and Pharmacotherapy of Depression
Saletu, B., Anderer, P., & Saletu-Zyhlarz, G. M. (2010) · Clinical EEG and Neuroscience · doi:10.1177/155005941004100407 · Cited by 123
Self-citationMitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent
Li, Y., Couch, L., Higuchi, M., Fang, J.-L., & Guo, L. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs100 · Cited by 120
“74lM) (Saletu et al., 1986), and plasma concentrations were higher in young females and in elderly patients of both sexes (Warrington, 1991).”
BackgroundBiomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects
Dumont, G. J. H., De Visser, S. J., Cohen, A. F., & Van Gerven, J. M. A. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02342.x · Cited by 107
Effects of sertraline on autonomic and cognitive functions in healthy volunteers
Siepmann, M., Grossmann, J., M�ck-Weymann, M., & Kirch, W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1448-4 · Cited by 105
“Our results are in line with a previous study demonstrat- ing an increase in beta power with single doses of 200 and 400 mg sertraline in healthy young volunteers (Saletu et al. 1986).”
BackgroundResultInfluentialPehrson, A. L., Leiser, S. C., Gulinello, M., Dale, E., Li, Y., Waller, J. A., & Sanchez, C. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.044 · Cited by 91
PharmGKB summary: sertraline pathway, pharmacokinetics
Huddart, R., Hicks, J. K., Ramsey, L. B., Strawn, J. R., Smith, D. M., Babilonia, M. B., Altman, R. B., & Klein, T. E. (2019) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000392 · Cited by 94
Saletu, B., Anderer, P., Saletu-Zyhlarz, G. M., Arnold, O., & Pascual-Marqui, R. D. (2002) · PubMed · Cited by 102
Self-citationSaletu, B., Frey, R., Krupka, M., Anderer, P., Grfulberger, J., & See, W. R. (1991) · Sleep · doi:10.1093/sleep/14.5.439 · Cited by 88
Self-citationLozano‐Soldevilla, D. (2018) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2018.00023 · Cited by 96
“…of serotonergic enhancers (Venlafaxine, Tianeptine, Ecstasy, Ayahuasca, Psylocibin, LSD) seem to decrease posterior alpha power during both resting (Saletu et al., 1986, 1992; Riba et al., 2002, 2004; Muthukumaraswamy et al., 2013a; Kometer et al., 2015; Schenberg et al., 2015; Carhart-Harris et…”
BackgroundHunter, A. M., Cook, I. A., & Leuchter, A. F. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.12.002 · Cited by 106
The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants
Alhaj, H., Wisniewski, G., & McAllister-Williams, R. H. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110388323 · Cited by 78
“…spectrum in man is also inferred from findings of acute administration of selective serotonin reuptake inhibitors (SSRIs) causing such a shift (Saletu et al., 1986) and that pindolol mimics, rather than blocks, the effect of buspirone on the awake EEG (McAllister-Williams and Massey, 2003).”
BackgroundResultChen, S., Xuan, J., Wan, L., Lin, H., Couch, L., Mei, N., Dobrovolsky, V. N., & Guo, L. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kft254 · Cited by 75
Effects of Selective Serotonin Reuptake Inhibitors on Objective and Subjective Sleep Quality
Oberndorfer, S., Saletu-Zyhlarz, G., & Saletu, B. (2000) · Neuropsychobiology · doi:10.1159/000026676 · Cited by 69
Self-citationSertraline induces endoplasmic reticulum stress in hepatic cells
Chen, S., Xuan, J., Couch, L. H., Iyer, A., Wu, Y., Li, Q., & Guo, L. (2014) · Toxicology · doi:10.1016/j.tox.2014.05.007 · Cited by 71
Depression and Sleep Disorders: Clinical Relevance, Economic Burden and Pharmacological Treatment
Brunello, N., Armitage, R., Feinberg, I., Holsboer-Trachsler, E., Léger, D., Linkowski, P., Mendelson, W. B., Racagni, G., Saletu, B., Sharpley, A. L., et al. (2000) · Neuropsychobiology · doi:10.1159/000026680 · Cited by 65
Self-citationPharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology.
Saletu, B., Grunberger, J., Anderer, P., Linzmayer, L., Semlitsch, H., & Magni, G. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04087.x · Cited by 64
Self-citationMyers, R. D., & Quarfordt, S. D. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90107-d · Cited by 62
Cognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder
Hindmarch, I. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02085.x · Cited by 61
EEG correlates of acute and chronic paroxetine treatment in depression
Knott, V., Mahoney, C., Kennedy, S. H., & Evans, K. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00308-1 · Cited by 58
Hyun, J., Baik, M., & Kang, U. G. (2011) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2011.9.2.78 · Cited by 49
Clinical trials of potential antidepressants: to what extent are the elderly represented: a review
Giron, M. S. T., Fastbom, J., & Winblad, B. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1273 · Cited by 49
Lucangioli, S. E., Hermida, L. G., Tripodi, V. P., Rodrı́guez, V. G., López, E. E., Rouge, P. D., & Carducci, C. N. (2000) · Journal of Chromatography A · doi:10.1016/s0021-9673(99)00881-x · Cited by 47
Noehr‐Jensen, L., Zwisler, S. T., Larsen, F., Sindrup, S. H., Damkier, P., Nielsen, F., & Brøsen, K. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0657-0 · Cited by 45
“This was surprising, considering the mydriatic effects demonstrated in a study of citalopram [12] and studies of other SSRIs [12, 20 , 21].”
ResultXia, D., Zhang, Y.-T., Xu, G., Yan, W., Pan, X., & Tong, J. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1287358 · Cited by 46
“74 lmol/L, respectively [15,22,23], which was far lower than the dose of sertraline we used in this study (about 12 and 20lmol/L).”
MethodIdentification of 5-HT3 recognition sites in the ferret area postrema
Barnes, N. M., Costall, B., Naylor, R. J., & Tattersall, F. D. (1988) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1988.tb05312.x · Cited by 42
Munro, C. A., Brandt, J., Leoutsakos, J., Steele, C. D., Samus, Q. M., Steinberg, M., Rabins, P. V., & Lyketsos, C. G. (2004) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200409000-00007 · Cited by 43
Patat, A. A., Troy, S. M., Burke, J., Trocherie, S., Danjou, P., Coz, F. L., Allain, H., & Gandon, J. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04423.x · Cited by 33
Schlösser, R. G. M., Roschke, J., Rossbach, W., & Benkert, O. (1998) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00080-1 · Cited by 31
Clozapine Increases EEG Photic Driving in Clinical Responders
Jin, Y., Potkin, S. G., & Sandman, C. A. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.2.263 · Cited by 29
Saletu, B., GR�NBERGER, J., Anderer, P., Linzmayer, L., & Saletu-Zyhlarz, G. M. (1996) · Journal of Neural Transmission · doi:10.1007/bf01292627 · Cited by 28
“1985), zimelidine (Saletu et al., 1986), sertraline (Saletu et al.”
Self-citationMcAllister-Williams, H., Massey, A. E., & Fairchild, G. F. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107078292 · Cited by 26
“…mediated negative shift in the EEG frequency spectrum in man is also inferred from findings of acute administration of SSRIs causing such a shift (Saletu et al., 1986) and that pindolol mimics, rather than blocks, the effect of buspirone on the awake EEG (McAllister-Williams and Massey, 2003).”
ResultBarbanoj, M. J., Clos, S., Romero, S., Morte, A., Giménez, S., Lorenzo, J. L., Luque, A., & Dal−Ré, R. (2005) · Neuropsychobiology · doi:10.1159/000085206 · Cited by 27
“Indeed, this is consistent with the pharmaco-EEG profiles of other SSRIs, such as sertraline [”
ResultPopulation Pharmacokinetics of Sertraline in Healthy Subjects: a Model-Based Meta-analysis
Alhadab, A. A., & Brundage, R. C. (2020) · The AAPS Journal · doi:10.1208/s12248-020-00455-y · Cited by 25
“V3 multiple (L) Peripheral volume of distribution for multiple dose 1350 (10) 1371 (1044–1755)”
BackgroundWiener, H. L., Kramer, H. K., & Reith, M. E. A. (1990) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)82133-7 · Cited by 23
Sertraline: A New Specific Serotonin Reuptake Blocker
Guthrie, S. K. (1991) · DICP · doi:10.1177/106002809102500910 · Cited by 23
Herron, K. A., Dijk, D., Dean, P., Seiss, E., & Sterr, A. (2014) · BioMed Research International · doi:10.1155/2014/794086 · Cited by 21
Safer, D. J. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000564 · Cited by 19
Functional effects of agents differentially selective to noradrenergic or serotonergic systems
Tranter, R., HEALY, H., Cattell, D., & HEALY, D. (2002) · Psychological Medicine · doi:10.1017/s0033291701005086 · Cited by 20
Abbas, R., Riley, S., LaBadie, R. R., Bachinsky, M., Chappell, P. B., Crownover, P. H., & Damle, B. D. (2019) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.749 · Cited by 17
Schulkens, J. E. M., Deckers, K., Jenniskens, M., Blokland, A., Verhey, F. R. J., & Sobczak, S. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221080462 · Cited by 18
“It should be noted that these acute effects may be dose-dependent (Saletu et al., 1986).”
BackgroundSexual dysfunction in depression
Michael, A., & O'Keane, V. (2000) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/1099-1077(200007)15:5<337::aid-hup207>3.0.co;2-h · Cited by 103
Schwartzmann, B., Chatterjee, R., Vaghei, Y., Quilty, L. C., Allen, T. A., Arnott, S. R., Atluri, S., Blier, P., Dhami, P., Foster, J. A., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03110-8 · Cited by 19
McAllister-Williams, H., Alhaj, H. A., Massey, A. E., Pankiv, J., & Reckermann, U. (2013) · Psychological Medicine · doi:10.1017/s0033291713001475 · Cited by 15
“Third, acute administration of selective serotonin reuptake inhibitors (SSRIs), which increase 5-HT in the raphé leading to somatodendritic 5-HT1A activation (Bel & Artigas, 1992), causes a similar shift in the EEG (Saletu et al. 1986).”
BackgroundClark, N. A., & ALEXANDER, B. K. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19101 · Cited by 13
Sertraline Induces Toxicity and Behavioral Alterations in Planarians
Thumé, I. S., & Frizzo, M. E. (2017) · BioMed Research International · doi:10.1155/2017/5792621 · Cited by 15
“[36] reported that a single oral dose of 400mg sertraline administered to healthy volunteers resulted in a plasma concentration of ∼0.”
BackgroundArnold, O., Saletu, B., Anderer, P., Assandri, A., Padova, C. D., Corrado, M. E., & Saletu-Zyhlarz, G. M. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.01.004 · Cited by 12
Self-citationAlmurjan, A., Macfarlane, H., & Badhan, R. (2021) · Biopharmaceutics & drug disposition · doi:10.1002/bdd.2278 · Cited by 9
“…50 mg oral doses reported on day 30 (Ronfeld et al., 1997) for males (red) and females (green); (c) 100, 200, and 400 mg single doses of sertraline (Saletu et al., 1986); (d) Forest plot showing the predicted mean ± SD over the observed ratio of pharmacokinetic parameters in subjects, with the…”
BackgroundEEG profile of litoxetine after single and repeated administration in healthy volunteers.
Patat, A. A., Trocherie, S., Thebault, J. J., Rosenzweig, P., Dubruc, C., Bianchetti, G., Morselli, P. L., & Court, L. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04255.x · Cited by 10
Saletu, B., Anderer, P., Linzmayer, L., Semlitsch, H. V., Lindeck‐Pozza, E., Assandri, A., Padova, C. D., & Saletu-Zyhlarz, G. M. (2002) · Journal of Neural Transmission · doi:10.1007/s00702-002-0768-6 · Cited by 9
Self-citationGoudie, A. J., Dubicki, W., & Leathley, M. J. (1988) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1988.tb05217.x · Cited by 9
Sertraline reduces glutamate uptake in human platelets
Rodrigues, D. O., Bristot, I. J., Klamt, F., & Frizzo, M. E. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.10.014 · Cited by 9
“As a reference, Saletu et al. (1986) reported that a single oral dose of 400 mg sertraline administered to healthy volunteers resulted in maximum plasma concentrations of this SSRI of 253.20 ± 112.29 ng/mL (~ 0.74 µM).”
BackgroundInfluentialJang, J.-H., & Jeong, S. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.109319 · Cited by 7
Husserlian Self-Awareness and Selective Serotonin Reuptake Inhibitors
Hadreas, P. (2010) · Philosophy, psychiatry & psychology · doi:10.1353/ppp.0.0279 · Cited by 5
“In some cases these studies have been available for decades (Grunberger and Saletu 1980; Saletu et al. 1986; Warrington et al. 1989; Healy 2000).”
BackgroundA Sertraline-Intoxicated Driver
Rohrig, T. P., & Goodson, L. J. (2004) · Journal of Analytical Toxicology · doi:10.1093/jat/28.8.689 · Cited by 7
An Overview of Investigational Antidepressants
Berwish, N. J., & Amsterdam, J. D. (1989) · Psychosomatics · doi:10.1016/s0033-3182(89)72312-4 · Cited by 7
Saletu-Zyhlarz, G. M., Anderer, P., Linzmayer, L., Semlitsch, H. V., Assandri, A., Prause, W., Abu‐Bakr, M. H., Lindeck‐Pozza, E., & Saletu, B. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002924 · Cited by 7
Self-citationPatrick, K. S., & Markowitz, J. S. (1997) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/(sici)1099-1077(199711/12)12:6<527::aid-hup932>3.0.co;2-u · Cited by 132
Effets EEG quantifies et psychometriques de 3 doses de dexfenfluramine chez l'adulte jeune
Baud, P., Roch, K. L., & Sebban, C. (1989) · Neurophysiologie Clinique · doi:10.1016/s0987-7053(89)80041-3 · Cited by 2
Death, Dependence and Deception
Healy, D., & Aldred, G. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104046527 · Cited by 2
“Saletu et al. (1986) found a dosedependent induction of agitation on sertraline in volunteers who had not been on previous treatment and there is at least one unpublished phase one study involving sertraline, which led all volunteers taking sertraline to discontinue because of agitation (again,…”
BackgroundResultMcCall, W. V., Dzurny, T. N., McCloud, L., Miller, B. J., Surya, S., & Rosenquist, P. B. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.05.038 · Cited by 1
The cytotoxic effect of antidepressants sertraline on human cervical cancer (HeLa) cells
Khodashahri, F. A., Sahraee, S., & Rachmawati, H. (2022) · Journal of Biological Studies · doi:10.62400/jbs.v5i1.6377 · Cited by 1
Conflicts of Interest in Biomedical Research Harm Children With and Without Disabilities
Sharav, V. H. (2004) · Journal of Disability Policy Studies · doi:10.1177/10442073040150010801 · Cited by 3
Dexfenfluramine Profile in Quantitative EEG and Its Topographical Aspects
Sebban, C., Roch, K. L., Benkemoun, G., Debouzy, C., & Baud, P. (1989) · Springer eBooks · doi:10.1007/978-3-642-72658-3_31 · Cited by 1
EEGs and ERPs in bipolar disorders
McAllister-Williams, H. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107477278.013
Human psychopharmacology of second generation antidepressants.
Fairweather, D. B. (1996) · University of Surrey Open Research repository
von Bruchhausen, F., Ebel, S., Hackenthal, E., Holzgrabe, U., Albinus, M., Amschler, G., Angerer, E. V., Arras‐Reiter, C., Bauer, A., Bauer, P., et al. (1999) · Springer eBooks · doi:10.1007/978-3-642-58388-9_8
EEGs and ERPs in Bipolar Disorders
McAllister-Williams, H. (2007) · Medical psychiatry · doi:10.3109/9781420021158.012
Metadata
- Authors
- Saletu, B., Gr�nberger, J., & Linzmayer, L.
- Affiliations
- University of Vienna (AT)
- Venue
- Journal of Neural Transmission
- Published
- 1986-09
- Volume
- 67
- Issue
- 3-4
- Pages
- 241-266
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2035578288
- Cited by
- 78
- References
- 42
- Citations by year
- 2026: 1 · 2024: 2 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 2
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- sertraline, zimelidine, selective serotonin reuptake inhibitors, pharmaco-EEG, plasma drug concentration, dose-dependent effects, sustained attention, psychometric performance, psychophysiological effects, pupil dilation, antidepressants, pharmacodynamics, adverse effects, blood pressure, pulse rate
- MeSH terms
- Adult, Brain, Double-Blind Method, Electroencephalography, Female, Humans, Male, Mental Processes, Naphthalenes, Psychological Tests, Psychotropic Drugs, Zimeldine, 1-Naphthylamine, Sertraline
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.